ArticleInternational journal of hematology2025
Favorable outcomes of de novo advanced phases of pediatric chronic myeloid leukemia in the tyrosine kinase inhibitor era.
Toshihide Yoshikawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.